🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Phase 1

Lopinavir/Ritonavir in PLWH With High-Grade AIN NCT05334004Phase 11 site📍 Madison University of Wisconsin, Madison · Tests: Lopinavir / Ritonavir ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participants NCT06787144Phase 14 sites📍 Akita📍 Sapporo📍 Suita-shi Enliven Therapeutics · Tests: ELVN-001 IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors NCT05958121Phase 1, Phase 229 sites📍 Heidelberg📍 Heidelberg📍 Mannheim Immatics Biotechnologies GmbH · Tests: IMA402, IMA402 and checkpoint inhibitor, IMA402 and chemotherapy, IMA402 and IMA401, IMA402 and monoclonal antibody A Phase I First-in-Human Study of GenSci128 in Patients With Solid Tumors Harboring a TP53 Y220C Mutation NCT06908434Phase 11 site📍 Shanghai Changchun GeneScience Pharmaceutical Co., Ltd. · Tests: GenSci128 tablets A Study of TY-2699a in Patients With Locally Advanced or Metastatic Solid Tumors NCT05866692Phase 12 sites📍 Beijing📍 Jinan TYK Medicines, Inc · Tests: TY-2699a Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus NCT06964087Phase 25 sites📍 Birmingham📍 Walnut Creek📍 Aurora Op-T LLC · Tests: OPT101, OPT101 Placebo to Match (PTM) Tirelizumab in Combination With Carboplatin and Albumin-binding Paclitaxel for Neoadjuvant Therapy in HNSCC NCT05941338Phase 21 site📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Tests: Tirelizumab ,+Carboplatin+albumin-bound paclitaxel VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma NCT03556228Phase 1, Phase 215 sites📍 Santa Rosa📍 Hartford📍 Washington D.C. VM Oncology, LLC · Tests: VMD-928 100 mg Tablet, VMD-928 Tablet and Pembrolizumab (200 mg) Phase 4, Double-blind Study Evaluating the Response on Computed Tomography (CT) Lung Density Decline Rates of Respreeza / Zemaira Weekly for 3 Years in Adults With alpha1 Antitrypsin Deficiency (AATD) NCT07326592Phase 42 sites📍 Aalborg📍 Vejle CSL Behring · Tests: CE1226 Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06) NCT06780111Phase 1, Phase 252 sites📍 Pittsburgh📍 Natal📍 Porto Alegre Merck Sharp & Dohme LLC · Tests: Pembrolizumab, I-DXd, Leucovorin, Levoleucovorin, 5-Fluorouracil (5-FU) The Safety, Tolerability and Preliminary Efficacy of NouvNeu001 for Early-onset Parkinson's Disease NCT06608355Phase 11 site📍 Wuhan iRegene Therapeutics Co., Ltd. · Tests: Human Dopaminergic Progenitor Cells A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML NCT05735184Phase 144 sites📍 Phoenix📍 La Jolla📍 Los Angeles Kura Oncology, Inc. · Tests: Ziftomenib, Venetoclax, Azacitidine, Daunorubicin, Cytarabine Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder NCT06538558Phase 11 site📍 Indianapolis Proniras Corporation · Tests: Tezampanel, Placebo Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs NCT06111638Phase 2, Phase 310 sites📍 Beijing📍 Guangzhou📍 Guiyang Shanghai Xinzhi BioMed Co., Ltd. · Tests: Single dose intravenous injection of BBM-H803 Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors NCT06821048Phase 11 site📍 Hangzhou Weijia Fang, MD · Tests: Intraperitoneal infusion of FAST CEA-targeted CAR-T Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B NCT06680232Phase 17 sites📍 Boston📍 Clichy📍 Hong Kong Precision BioSciences, Inc. · Tests: PBGENE-HBV CD70 Targeted CAR-T Cells in CD70 Positive Relapsed/Refractory Lymphoma NCT05948033Phase 1, Phase 21 site📍 Beijing Chinese PLA General Hospital · Tests: CD70-targeting CAR-T cells A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD) NCT07227207Phase 1, Phase 28 sites📍 Jacksonville📍 Boston📍 Rochester Tessera Therapeutics, Inc. · Tests: TSRA-196 A Study to Learn How Different Amounts of the Study Medicine Called PF-08065010 Are Tolerated and Act in the Body of Healthy Adults NCT07235163Phase 11 site📍 Brussels Pfizer · Tests: PF-08065010, Placebo TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies NCT06484816Phase 11 site📍 Hangzhou Shenzhen TargetRx Co., Ltd. · Tests: TGRX-1942 Naltrexone and Propranolol Combined With Immunotherapy NCT05968690Phase 11 site📍 New Brunswick Sarah Weiss · Tests: Propranolol, Naltrexone A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites📍 Los Angeles📍 Grand Rapids📍 Columbus Tanabe Pharma America, Inc. · Tests: MT-4561 A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies NCT07195916Phase 122 sites📍 Duarte📍 La Jolla📍 Ann Arbor Incyte Corporation · Tests: INCA036873 DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau NCT07142278Phase 11 site📍 Miami Lakes Nuravax, Inc. · Tests: DUVAX 200 µg, DUVAX 400 µg, Placebo (Adjuvant only) Study of GS-2426 in Participants With Advanced Solid Tumors NCT07601243Phase 16 sites📍 Boston📍 Grand Rapids📍 East Brunswick Gilead Sciences · Tests: GS-2426 Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy NCT04912843Phase 2, Phase 31 site📍 Beijing Wuhan Neurophth Biotechnology Limited Company · Tests: NR082 injection, Sham Injection A Study to Investigate Pharmacokinetics (PK), Safety, and Tolerability of VH4367310 in Healthy Adult Participants NCT07818915Phase 12 sites📍 Glendale📍 Baltimore ViiV Healthcare · Tests: VH4367310, Placebo A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors NCT06311578Phase 110 sites📍 New York📍 Philadelphia📍 Pittsburgh Johnson & Johnson Enterprise Innovation Inc. · Tests: JNJ-87704916, Cetrelimab, Standard of Care PD(L)-1 CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL NCT06559189Phase 11 site📍 Aurora University of Colorado, Denver · Tests: CD19x22 CAR T The Application of "HUAXI Hole 1" in Reverse-sequence Endoscopic Nipple-sparing Mastectomy With Direct-to-implant Breast Reconstruction NCT06995118NA20 sites📍 Fuzhou📍 Guangzhou📍 Anyang Du Zhenggui · Tests: HUAXI hole 1
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy